Scientists Report 'Rogue Antibodies' Behind Severe Clotting With COVID-19

These autoantibodies are more common in people with autoimmune disorders, such as lupus, but can be activated in response to viral infections and also activate other immune responses.

Related Keywords

,Yogen Kanthi ,Us National Heart ,Us National Institutes Of Health ,Blood Institute ,Laboratory Of Vascular Thrombosis ,Healthday News ,Vascular Thrombosis ,